Function and therapeutic value of astrocytes in neurological diseases

HG Lee, MA Wheeler, FJ Quintana - Nature reviews Drug discovery, 2022 - nature.com
Astrocytes are abundant glial cells in the central nervous system (CNS) that perform diverse
functions in health and disease. Astrocyte dysfunction is found in numerous diseases …

Dysmaturation of premature brain: importance, cellular mechanisms, and potential interventions

JJ Volpe - Pediatric neurology, 2019 - Elsevier
Prematurity, especially preterm birth (less than 32 weeks' gestation), is common and
associated with high rates of both survival and neurodevelopmental disability, especially …

[HTML][HTML] Dendrimer-based drug delivery systems for brain targeting

Y Zhu, C Liu, Z Pang - Biomolecules, 2019 - mdpi.com
Human neuroscience has made remarkable progress in understanding basic aspects of
functional organization; it is a renowned fact that the blood–brain barrier (BBB) impedes the …

Brain-targeted drug delivery-nanovesicles directed to specific brain cells by brain-targeting ligands

R Moreira, C Nóbrega, LP de Almeida… - Journal of …, 2024 - Springer
Neurodegenerative diseases are characterized by extensive loss of function or death of
brain cells, hampering the life quality of patients. Brain-targeted drug delivery is challenging …

Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial

AM Gusdon, N Faraday, JS Aita, S Kumar… - Science translational …, 2022 - science.org
Hyperinflammation triggered by SARS-CoV-2 is a major cause of disease severity, with
activated macrophages implicated in this response. OP-101, a hydroxyl-polyamidoamine …

Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries

H Amani, R Habibey, SJ Hajmiresmail… - Journal of Materials …, 2017 - pubs.rsc.org
Organ ischemia with inadequate oxygen supply followed by reperfusion (which initiates a
complex of inflammatory responses and oxidative stress) occurs in different clinical …

Dendrimer‐based nanocarriers: a versatile platform for drug delivery

HJ Hsu, J Bugno, S Lee, S Hong - … Reviews: Nanomedicine and …, 2017 - Wiley Online Library
Advances in nanotechnology have had profound impacts on therapeutic delivery, leading to
the development of nanomaterials engineered with large carrying capabilities and targeting …

Stimuli-responsive dendrimers in drug delivery

H Wang, Q Huang, H Chang, J **ao, Y Cheng - Biomaterials science, 2016 - pubs.rsc.org
Dendrimers have shown great promise as carriers in drug delivery due to their unique
structures and superior properties. However, the precise control of payload release from a …

Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics

A Sharma, K Liaw, R Sharma, Z Zhang… - …, 2018 - pmc.ncbi.nlm.nih.gov
Mitochondrial oxidative stress is associated with many neurodegenerative diseases, such as
traumatic brain injury (TBI). Targeted delivery of antioxidants to mitochondria has failed to …

Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury

R Sharma, SP Kambhampati, Z Zhang… - Journal of Controlled …, 2020 - Elsevier
Traumatic brain injury (TBI) is a significant medical problem with limited treatment options
and is one of the main causes of life-long disability. Neuroinflammation orchestrated by …